TY - JOUR
T1 - Associations of visit-to-visit lipid variability with coronary artery calcification and cardiovascular event in statin-naïve Koreans
AU - Kang, Jeonggyu
AU - Kim, Byung Jin
N1 - Publisher Copyright:
© 2025 The Author(s). Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact [email protected] for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site - for further information please contact [email protected].
PY - 2025/9/1
Y1 - 2025/9/1
N2 - Aims This study investigated the association of visit-to-visit lipid variability with both coronary artery calcification (CAC) and cardiovascular event risk among statin-naïve individuals. Methods and results We conducted a cross-sectional analysis of 59 879 participants whose lipid profiles were measured 4-6 times before or on the day of CAC scanning and a cohort study of 85 359 individuals who underwent at least five lipid tests with additional follow-up to identify cardiovascular events. Lipid variability was quantified using standard deviation, coefficient of variation, and variability independent of the mean (VIM). Cardiovascular events were identified using self-reported coronary artery disease and stroke. Among lipid profiles, the highest quartile of low-density lipoprotein cholesterol (LDL-C) variability (VIM) showed a 1.42-fold increased CAC score [95% confidence interval (CI): 1.22-1.65] compared to the lowest quartile. Furthermore, the VIM for total cholesterol, triglyceride, and non-high-density lipoprotein cholesterol levels was positively associated with CAC scores. During a median follow-up of 2.8 years, 664 cases of cardiovascular events were identified. Among the lipid profiles, only LDL-C variability was associated with an increased risk of cardiovascular events, with a hazard ratio of 1.41 (95% CI: 1.13-1.75) for those with the highest VIM variability. Conclusion These findings suggest that visit-to-visit lipid variability is independently associated with subclinical coronary atherosclerosis and cardiovascular risk in statin-naïve individuals. Clinicians need to be aware of the potential implications of lipid variability and consider monitoring lipid fluctuations as part of a comprehensive cardiovascular risk assessment.
AB - Aims This study investigated the association of visit-to-visit lipid variability with both coronary artery calcification (CAC) and cardiovascular event risk among statin-naïve individuals. Methods and results We conducted a cross-sectional analysis of 59 879 participants whose lipid profiles were measured 4-6 times before or on the day of CAC scanning and a cohort study of 85 359 individuals who underwent at least five lipid tests with additional follow-up to identify cardiovascular events. Lipid variability was quantified using standard deviation, coefficient of variation, and variability independent of the mean (VIM). Cardiovascular events were identified using self-reported coronary artery disease and stroke. Among lipid profiles, the highest quartile of low-density lipoprotein cholesterol (LDL-C) variability (VIM) showed a 1.42-fold increased CAC score [95% confidence interval (CI): 1.22-1.65] compared to the lowest quartile. Furthermore, the VIM for total cholesterol, triglyceride, and non-high-density lipoprotein cholesterol levels was positively associated with CAC scores. During a median follow-up of 2.8 years, 664 cases of cardiovascular events were identified. Among the lipid profiles, only LDL-C variability was associated with an increased risk of cardiovascular events, with a hazard ratio of 1.41 (95% CI: 1.13-1.75) for those with the highest VIM variability. Conclusion These findings suggest that visit-to-visit lipid variability is independently associated with subclinical coronary atherosclerosis and cardiovascular risk in statin-naïve individuals. Clinicians need to be aware of the potential implications of lipid variability and consider monitoring lipid fluctuations as part of a comprehensive cardiovascular risk assessment.
KW - Cardiovascular disease
KW - Coronary artery calcification
KW - Low-density lipoprotein
KW - Statin-naïve individuals
KW - Visit-to-visit lipid variability
UR - https://www.scopus.com/pages/publications/105016711492
U2 - 10.1093/eurjpc/zwaf191
DO - 10.1093/eurjpc/zwaf191
M3 - Article
C2 - 40350300
AN - SCOPUS:105016711492
SN - 2047-4873
VL - 32
SP - 1247
EP - 1256
JO - European Journal of Preventive Cardiology
JF - European Journal of Preventive Cardiology
IS - 13
ER -